Brief: Biovaxys Says Co And Horizon Technology Finance Corp Execute Amendment To Asset Purchase Agreement
30/05/2025 01:42
May 29 (Reuters) - Biovaxys Technology Corp BIOV.CD:
BIOVAXYS AND HORIZON TECHNOLOGY FINANCE CORP EXECUTE AMENDMENT TO ASSET PURCHASE AGREEMENT ("APA")
BIOVAXYS TECHNOLOGY CORP - NEW AMENDMENT LOWERS CAPITAL RAISE MILESTONE TO $2,028,636
Source text: ID:nCNWlyFRSa
Further company coverage: BIOV.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Horizon Technology Finance
See all newsHorizon Technology Finance Q3 net investment income per share falls
Horizon Technology Finance Corporation expected to post earnings of 18 cents a share - Earnings Preview
Brief: Horizon Technology Finance Provides $15 Million Loan Facility To Bioness Medical
U.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC Solutions
Horizon Technology Finance Corporation reports results for the quarter ended June 30 - Earnings Summary